Michael Toboni (@tabonesmt) 's Twitter Profile
Michael Toboni

@tabonesmt

Born & Raised San Franciscan. Gyros, 9ers, Dubs. Assistant Professor, Gynecologic Oncologist at UAB, WashU. UAB. USC, Keck. Georgetown Alum

ID: 155715542

calendar_today14-06-2010 22:30:00

1,1K Tweet

363 Followers

384 Following

Amanda Nickles Fader, MD (@amandanfader) 's Twitter Profile Photo

Thrilled to be partnering w/ The GOG Foundation Inc. & supported by FdtnForWomensCancer for BRIDGES 2.0, a fabulous longitudinal GYN cancer clinical trials🔬& career development program.👩‍⚕️Apps are OPEN! We look forward to meeting the next gen BRIDGES scholars! Dr Herzog Ginger J. Gardner Angeles Secord SGO

UChicago Ob/Gyn (@uchicago_obgyn) 's Twitter Profile Photo

Very excited for our Herbst Lecturer, Dr. Amanda Nickles Fader, to share her expertise in uncommon #cancers. Learn with us this Friday morning! Sign up here➡️obgyn.uchicago.edu/grand-rounds #MedEd Amanda Nickles Fader, MD UChicagoCancerCenter

Very excited for our Herbst Lecturer, Dr. Amanda Nickles Fader, to share her expertise in uncommon #cancers. Learn with us this Friday morning! 
Sign up here➡️obgyn.uchicago.edu/grand-rounds
#MedEd <a href="/amandanfader/">Amanda Nickles Fader, MD</a> <a href="/UCCancerCenter/">UChicagoCancerCenter</a>
Amanda Nickles Fader, MD (@amandanfader) 's Twitter Profile Photo

As we recognize Uterine Cancer Awareness Month, I direct our members and non-members to the 🌟FANTASTIC 🌟SGO educational content 📚on uterine/endometrial cancer symptoms 🩸, treatment💉, prevention, surgical 😷films 🎥, journal clubs 📰, and so much more! 🔥Free to members!

Amanda Nickles Fader, MD (@amandanfader) 's Twitter Profile Photo

Wow, the GREAT news continues for drug approvals in endometrial cancer! Today, pembro+chemo FDA-approved for pts w/ dMMR AND pMMR advanced/recurrent disease! This is historic & progress for our pts; honored to be part of the study team! Congrats ⁦Ramez Eskander⁩, ⁦NRG Oncology

Wow, the GREAT news continues for drug approvals in endometrial cancer! Today, pembro+chemo FDA-approved for pts w/ dMMR AND pMMR advanced/recurrent disease! This is historic &amp; progress for our pts; honored to be part of the study team!  Congrats ⁦<a href="/rne_md/">Ramez Eskander</a>⁩, ⁦<a href="/NRGonc/">NRG Oncology</a>⁩
@GynOncJnls (@gynoncjnls) 's Twitter Profile Photo

Long-term follow-up of efficacy and safety of #selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study SGO IGCS ESGO ASCO pubmed.ncbi.nlm.nih.gov/38834399/

Long-term follow-up of efficacy and safety of #selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
<a href="/SGO_org/">SGO</a> <a href="/IGCSociety/">IGCS</a> <a href="/ESGO_society/">ESGO</a> <a href="/ASCO/">ASCO</a> pubmed.ncbi.nlm.nih.gov/38834399/